Quotes with Resistance & Support
Market Information

Buy Dishman Pharma, target of Rs 230: Hem Securities

Posted on: May 30th 2009 in Brokerage Recommendations.

Hem Securities has recommended a buy rating on Dishman Pharmaceuticals & Chemicals with price target of Rs 230 in its May 28, 2009 research report. “The company is a leader in CRAM business amongst the largest Indian pharmaceutical companies. Moreover, in global crisis and wea…

Read More..

read more


+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments